IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKalkan, Rasime
dc.contributor.authorAtli, Emine Ikbal
dc.contributor.authorOzdemir, Muhsin
dc.contributor.authorCiftci, Evrim
dc.contributor.authorAydin, Hasan Emre
dc.contributor.authorArtan, Sevilhan
dc.contributor.authorArslantas, Ali
dc.date.accessioned2025-10-16T15:32:07Z
dc.date.issued2015
dc.identifier.doi10.1016/j.gene.2014.10.027
dc.identifier.otherWOS:000345483100011
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9100
dc.publisherELSEVIER
dc.sourceGENE
dc.subjectPrimary glioblastoma
dc.subjectIDH1 mutation
dc.subjectMGMT methylation
dc.subjectMS\\-HRM
dc.titleIDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS